Our research focuses on the development and clinical translation of novel quantitative Magnetic Resonance Imaging (MRI) technology, to improve the understanding, diagnosis and treatment of diseases.
Clinical decisions currently still heavily rely on invasive procedures, such as biopsy and surgical implants. There is a clinical need to develop non-invasive, low risk, time and cost efficient ways for better diagnosis and treatment management. Our goal is to address this clinical need by developing efficient MR imaging acquisition and post-processing framework to provide non-invasive, fast and comprehensive information for clinical decision support.
Ongoing work focuses on:
Magnetic Resonance Fingerprinting (MRF). MRF is a novel quantitative MR imaging technique developed in our lab which permits non-invasive quantification of multiple tissue properties within clinically feasible time.
Multi-parametric MR acquisition, reconstruction, signal modeling and post-processing.
Clinical translation of MR Fingerprinting in early detection and characterization of neurological diseases such as epilepsy, brain tumors, and multiple sclerosis.